Skip to Content Skip to Search
GSK Our Story

Our story

About us

We are a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer.

Pakistan West Wharf PSC QC
West Wharf PSC Quality Control

We have three global businesses that research, develop and manufacture innovative pharmaceutical medicines, vaccines and consumer healthcare products.

Our goal is to be one of the world’s most innovative, best performing and trusted healthcare companies.

Our values and expectations are at the heart of everything we do and help define our culture - so that together we can deliver extraordinary things for our patients and consumers and make GSK a brilliant place to work. 

Our values are Patient Focus, Transparency, Respect, Integrity.
Our expectations are Courage, Accountability, Development, Teamwork.

What we do

We aim to bring differentiated, high-quality and needed healthcare products to as many people as possible, with our three global businesses, scientific and technical know-how and talented people.


Immune system T-cells attacking a cancer cell


Herpes zoster virus of shingles

Consumer Healthcare

Novamin, a key technology in Sensodyne Repair and Protect

How we do it

Everyone at GSK is focused on our 3 long-term priorities – Innovation, Performance, Trust, all powered by our performance-focused culture.



Innovation is at the heart of delivering GSK’s purpose, by using our science to develop better medicines, vaccines, and consumer healthcare products. We invest in scientific and technical excellence to develop and launch a pipeline of new products that meet the needs of patients, payers and consumers.

  • $4.6bn

    adjusted R&D investment in 2020

  • 40

    new medicines in development at FY 2020

  • 17

    new vaccines in development at FY 2020


We deliver growth by investing effectively in our business, developing our people and executing competitively.

  • $34bn

    turnover in 2020

  • $9bn

    adjusted operating profit in 2020

  • $5.4bn

    free cash flow in 2020

  • $4bn

    dividends paid in 2020


We are a responsible company - using our science and technology to address health needs, we are focused on making our products affordable and available, and being a modern employer.

  • 84%

    employee engagement score on our latest employee survey

  • $250m

    donated in 2020 to community health programmes

  • 1st

    in Access to Medicines Index since the assessment began in 2008

Policies, codes and standards

Information regarding our codes of conduct, public policies, and other reporting information. 

Our core values of transparency, respect for people, integrity, and patient-focus guide us in everything we do. And our employees, our partners and our suppliers are expected to adhere to the strict codes of ethical conduct that support these values.

Pakistan policies

GSK Environment, Health, Safety & Sustainability Policy - Pakistan

To demonstrate EHS leadership and commitment and to establish a framework for making EHS integral to the management of GSK's business.

GSK Quality Policy - Pakistan

To demonstrate leadership and commitment to establish a framework for making Quality Management System integral to the management of GlaxoSmithKline business.

Global policies

GSK Code of Conduct 

Anti-Bribery and Corruption (ABAC) Program 

The Anti-Bribery and Corruption (ABAC) Program is part of GSK’s response to the threat and risk of bribery and corruption. The program includes the ABAC Handbook, which has been designed to assist internal and external parties understand corruption risk and identify people’s responsibilities to actively combat both real and perceived corruption. 

Third Party Oversight Programme

Our Third Party Oversight Programme helps control risks from third party business engagements with suppliers, distributors and other business partners. We want to work with business partners who share our commitment of high ethical standards and operating in a responsible way.

 Visit our global site for a complete list of global policies

Promotion and Scientific Engagement